NRX Pharmaceuticals Capital Expenditures (CapEx) Growth & History (NRXP)
NRX Pharmaceuticals's capital expenditures (capex) was $0 for fiscal 2024.
View full NRX Pharmaceuticals company overviewNRX Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$3,000 | — |
| 2023 | 2023-12-31 | $3,000 | −$7,000 | −70.00% |
| 2022 | 2022-12-31 | $10,000 | $3,000 | +42.86% |
| 2021 | 2021-12-31 | $7,000 | $5,000 | +250.00% |
| 2020 | 2020-12-31 | $2,000 | — | — |
NRX Pharmaceuticals quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | −$1,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$2,000 | — |
| Q2 2024 | 2024-06-30 | $0 | −$2,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$4,000 | — |
| Q4 2023 | 2023-12-31 | $1,000 | $0 | 0.00% |
| Q3 2023 | 2023-09-30 | $2,000 | −$3,000 | −60.00% |
| Q2 2023 | 2023-06-30 | $2,000 | −$1,000 | −33.33% |
| Q1 2023 | 2023-03-31 | $4,000 | $1,000 | +33.33% |
| Q4 2022 | 2022-12-31 | $1,000 | — | — |
| Q3 2022 | 2022-09-30 | $5,000 | $1,000 | +25.00% |
| Q2 2022 | 2022-06-30 | $3,000 | — | — |
| Q1 2022 | 2022-03-31 | $3,000 | — | — |
| Q3 2021 | 2021-09-30 | $4,000 | — | — |
NRX Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2020-12-31 and 2024-12-31, NRX Pharmaceuticals's capital expenditures (capex) decreased from $2,000 to $0, a change of −$2,000. The latest reported quarter, Q1 2025, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NRX Pharmaceuticals source filings ↗